Moreover, several studies on ovarian cancer, prostate cancer also indicated that IGHG1 promoted tumor migration and metastasis via modulating EMT [14] or MEK/ERK/c-Myc pathway [15]. Here, MAP2K7 is linked to ovarian carcinoma.